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A B S T R A C T
Mutations in the PKD1 or PKD2 genes are the cause of autosomal dominant polycystic kidney disease (ADPKD).
The encoded proteins localize within the cell membrane and primary cilia and are proposed to be involved in
mechanotransduction. Therefore, we evaluate shear stress dependent signaling in renal epithelial cells and the
relevance for ADPKD. Using RNA sequencing and pathway analysis, we compared gene expression of in vitro
shear stress treated Pkd1−/− renal epithelial cells and in vivo pre-cystic Pkd1del models. We show that shear
stress alters the same signaling pathways in Pkd1−/− renal epithelial cells and Pkd1wt controls. However, ex-
pression of a number of genes was slightly more induced by shear stress in Pkd1−/− cells, suggesting that Pkd1
has the function to restrain shear regulated signaling instead of being a mechano-sensing activator. We also
compared altered gene expression in Pkd1−/− cells during shear with in vivo transcriptome data of kidneys from
Pkd1del mice at three early pre-cystic time-points. This revealed overlap of a limited number of diﬀerentially
expressed genes. However, the overlap between cells and mice is much higher when looking at pathways and
molecular processes, largely due to altered expression of paralogous genes. Several of the altered pathways in the
in vitro and in vivo Pkd1del models are known to be implicated in ADPKD pathways, including PI3K-AKT, MAPK,
Hippo, calcium, Wnt, and TGF-β signaling. We hypothesize that increased activation of selected genes in renal
epithelial cells early upon Pkd1 gene disruption may disturb the balance in signaling and may contribute to cyst
formation.
1. Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is char-
acterized by formation of many ﬂuid-ﬁlled cysts and renal ﬁbrosis,
leading to deterioration or loss of renal function in adulthood [1,2].
ADPKD is caused by germline mutations in the PKD1 or PKD2 genes,
encoding polycystin-1 (PC-1) and polycystin-2 (PC-2), respectively
[3–5]. Somatic mutations in the unaﬀected allele of PKD1 or PKD2 can
initiate cyst formation, the so called “second hit”, but stochastic ﬂuc-
tuations in gene expression can also lower PC-1 or PC-2 below critical
levels [6,7].
The PC-1 and PC-2 proteins co-localize throughout the cell mem-
brane of renal epithelial cells, at the cell-cell contacts, extracellular
matrix (ECM) and primary cilia, where PC-2 functions as a non-
selective cation channel [8–10]. Primary cilia are central in organizing
signaling systems that sense environmental cues, triggered by ﬂuid ﬂow
and growth factor stimulation. Lack of the PC1-PC2 complex in cilia is
proposed to play a role in cyst formation [11,12]. Moreover, mutations
or deletions of other ciliary proteins can cause renal cysts in mouse
models and patients, indicating the role of cilia during cystogenesis
[13,14]. Several signaling pathways are modulated by cilium depen-
dent and independent shear stress responses of renal epithelial cells,
including Wnt, mTOR, STAT6/p100, TGF-β/ALK5 and MAPK signaling,
as well as Ca2+ inﬂux and Na+ and HCO3− reabsorption [9,15–25]. In
addition, receptors of various signaling pathways have been identiﬁed
in the primary cilium, including TGF-β, epidermal growth factor re-
ceptor (EGFR), Wnt and hedgehog signaling, suggesting that diﬀerent
signaling cascades are being regulated by this organelle [19,26–28].
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Cellular physiology and gene expression are determined by integration
and interaction of the diﬀerent signaling pathways, triggered by ﬂuid
shear stress and by growth factor or cytokine stimulation.
Luminal ﬂuid shear and growth factors related signaling are es-
sential for normal cell function, cell viability, tissue development and
maintenance of organs [29–32]. In the kidneys, urinary volume,
diuretics, and diet will expose the renal epithelial cells to variations in
hydrodynamic forces including ﬂuid shear stress, circumferential
stretch, and drag/torque on apical cilia and probably also on microvilli
[33]. For example, the kidney has the capacity to increase glomerular
ﬁltration rate in response to physiological stimuli. In addition, strong
variations in hydrodynamic forces and shear stress are common in
kidney diseases due to tubular dilation, obstruction and hyperﬁltration,
which occur in functional nephrons to compensate for lost glomeruli
and tubules [34]. Renal shear stress is increased after unilateral ne-
phrectomy [35,36], which accelerates cyst formation in Ift88−/− and
Pkd1−/− mouse models [37,38]. Therefore, we hypothesize that shear
stress induced alterations in cellular signaling may contribute to (early)
cystogenesis.
To study shear stress dependent signaling in ADPKD, we examined
the eﬀect of ﬂuid ﬂow in proximal tubular epithelial cells (PTECs)
without Pkd1 expression and compared this with Pkd1wt controls using
RNA sequencing. In addition, we compared diﬀerential gene expression
in Pkd1−/− PTECs during shear with in vivo transcriptome analysis of
pre-cystic kidneys in Pkd1del mice, in which ﬂuid ﬂow is still present.
Functional enrichment analysis revealed that several in vitro disturbed
signaling pathways in Pkd1−/− PTECs were also altered in pre-cystic
kidneys of Pkd1del mice.
2. Material and methods
2.1. Cell culture
SV40 large T-antigen immortalized murine proximal tubular epi-
thelial cells (PTEC; Pkd1−/− and Pkd1wt), derived from a Pkd1lox,lox
mouse, were generated and cultured as described previously [19,39].
Brieﬂy, cells were maintained at 37 °C and 5% CO2 in DMEM/F-12 with
GlutaMAX (Thermo Fisher Scientiﬁc; #31331-093) supplemented with
100 U/mL Penicillin-Streptomycin (Thermo Fisher Scientiﬁc; #15140-
122), 2% Ultroser G (Pall Corporation; #15950-017), 1x Insulin-
Transferrin-Selenium-Ethanolamine (Thermo Fisher Scientiﬁc; #51500-
056), 25 ng/L Prostaglandin E1 (Sigma-Aldrich; #P7527) and 30 ng/L
Hydrocortisone (Sigma-Aldrich; #H0135). Cell culture was monthly
tested without mycoplasma contamination using MycoAlert Myco-
plasma Detection Kit (Lonza; LT07-318). New ampules were started
after 15 passages.
2.2. Fluid shear stress stimulation and RNA sequencing
PTECs were exposed to laminar ﬂuid shear stress (1.9 dyn/cm2) in a
cone-plate device as described previously [19]. Brieﬂy, the cone-plate
device, adapted from Malek et al. [40], was designed for 3.5 cm cell
culture dishes (Greiner Bio-One). Cells were grown on collagen-I (Ad-
vanced BioMatrix; #5005) coated dishes until conﬂuence, followed by
24 h serum starvation, before the start of the treatment to exclude ef-
fects of serum-derived growth-factors and to synchronize cells and cilia
formation. Culture dishes were placed in the cone-plate ﬂow system and
incubated at 37 °C and 5% CO2. The conﬂuent cell monolayer of 9.6 cm2
was subjected to constant laminar (Re=0.3) ﬂuid shear stress, using
2ml serum-free DMEM/F-12 medium containing penicillin-strepto-
mycin, with viscosity (μ) of 0.0078 dyn s/cm2 [41], a cone with an
angle (α) of 2° and a velocity (ω) of 80 rpm, generating a ﬂuid shear
stress (τ= μω/α) of 1.9 dyn/cm2. Static control cells were incubated for
the same time in equal amounts of serum-free DMEM/F12 medium
containing penicillin-streptomycin at 37 °C and 5% CO2. Cilia formation
was checked on a parallel slide by immunoﬂuorescence using anti-
acetylated α-tubulin antibodies (Sigma Aldrich; #T6793) as previously
described [19].
RNA sequencing was performed on isolated mRNA from ﬂuid shear
stress treated PTECs or static controls (n=4 per condition) as pre-
viously described [20]. Brieﬂy, next generation sequencing (NGS) was
performed by ServiceXS (GenomeScan) using the Illumina® HiSeq 2500
platform. Illumina mRNA-Seq Sample Prep Kit was used to process the
samples according to the manufacturer’s protocol. Clustering and cDNA
sequencing using the Illumina cBot and HiSeq 2500 was performed
according manufacturer’s protocols. A concentration of 5.8 pM of cDNA
was used. All samples were run on Paired End mode and 125 bp long
reads. HiSeq control software HCS v2.2.38 was used. Image analysis,
base calling, and quality check was performed with the Illumina data
analysis pipeline RTA v1.18.61 and/or OLB v1.9 and Bcl2fastq v1.8.4.
At least 87.3% of bases had a Q-score ≥30. Reads were aligned to
mouse genome build GRCm38 - Ensembl using TopHat2 version 2.0.10
[42]. Gene expression was quantiﬁed using HTSeq-Count version 0.6.1
[43], using default options (stranded=no, mode=union). Diﬀerential
gene expression analysis was performed in R version 3.0.2 using DESeq
(Version1.16.0). Diﬀerentially expressed genes were selected with an
adjusted p-value (corrected for multiple hypotheses testing using Ben-
jamini and Hochberg’s False Discovery Rate method) of< 0.05. Counts
per million (CPM) values were calculated by dividing the read counts of
a gene by total read counts of all genes in a sample, which is a measure
for the abundance of the transcript. Only genes with average CPM > 2
were considered. Raw RNA sequencing data was deposited online at
http://www.ebi.ac.uk/arrayexpress/ (authors: S.J. Kunnen, D.J.M. Pe-
ters; year: 2018; ArrayExpress: E-MTAB-6640; ArrayExpress: E-MTAB-
6641).
2.3. Experimental animals and RNA sequencing
Tamoxifen inducible kidney-speciﬁc Pkd1-deletion mouse model
(tam-KspCad-CreERT2; Pkd1lox2-11;lox2-11, referred to as iKsp-Pkd1del)
and tamoxifen treatments were previously described [44–46]. Brieﬂy,
iKsp-Pkd1del male mice were fed with tamoxifen (5mg/day, 3 con-
secutive days) at adult age, i.e. between 13 to 14 weeks of age. Mice
euthanized at determined time points (2, 3, and 6 weeks after tamoxifen
treatment) had no visible signs of cystic disease (4 mice per time point).
Adult male mice that did not receive tamoxifen treatment were used as
Pkd1wt controls (5 mice). RNA sequencing was performed on isolated
mRNA from kidneys of iKsp-Pkd1del and Pkd1wt mice as previously
described [46]. The local animal experimental committee of the Leiden
University Medical Center and the Commission Biotechnology in Ani-
mals of the Dutch Ministry of Agriculture approved the experiments
performed. Animal experiments have been carried out in accordance
with the EU Directive 2010/63/EU for animal experiments.
2.4. Pathway analysis
Functional enrichment analysis was performed with the online tool
GeneTrail2 v1.5 (https://genetrail2.bioinf.uni-sb.de/) using standard
settings of the over-representation analysis enrichment algorithm with
correction for multiple hypotheses testing (FDR adjustment) according
to Benjamini and Yekutieli [47]. From this source we included pathway
databases (KEGG, BIOCARTA, REACTOME and WIKI). Up- and down-
regulated genes by ﬂuid shear stress were used as separate gene sets to
discriminate between generally up- and down-regulated pathways.
Terms with false discovery rate (FDR) < 0.01 were considered sig-
niﬁcantly enriched. Venn diagrams were made using Venny 2.1 (Oli-
veros, J.C. (2007–2015) Venny. An interactive tool for comparing lists
with Venn’s diagrams. http://bioinfogp.cnb.csic.es/tools/venny/index.
html).
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3. Results
3.1. Fluid shear stress induced transcriptional changes in Pkd1−/− PTECs
To study shear stress altered gene expression, Pkd1−/− proximal
tubular epithelial cells (PTEC) were exposed to ﬂuid shear of 1.9 dyn/
cm2. Static controls were incubated without ﬂuid ﬂow treatment in
equal amounts of medium. After 6 h ﬂuid-ﬂow or static exposure, total
RNA was isolated and gene expression was analyzed using next gen-
eration sequencing (NGS) on the Illumina HiSeq 2500 platform. From
the RNA sequencing data, the count per million (CPM) values were
calculated by dividing the read counts of a gene by total read counts of
all genes in a sample, which is a measure for the abundance of the
transcript (Suppl. Table S1). Low expressed genes with an average
CPM < 2 were excluded. In our previous study we presented the RNA
sequencing results of shear stress treated Pkd1wt PTECs [20], which we
used as shear stress control in this study (Fig. 1A).
After normalization, a total of 1749 genes were diﬀerentially ex-
pressed (p < 0.05; CPM > 2) upon shear stress stimulation in Pkd1−/
− PTECs (Table 1; Suppl. Table S2A). A heat map of Pkd1−/− PTEC
samples shows a clear distinction between ﬂuid shear stress treated
samples and static controls (Fig. 1B). RNA sequencing results were
compared to Pkd1wt PTECs, again showing that shear stress samples
clustered separately from the static controls, while the genotype has
less inﬂuence on the hierarchical clustering (Fig. 1C). The comparison
of Pkd1−/− and Pkd1wt PTEC shows an overlap of 1220 diﬀerentially
expressed genes (DEG) by shear stress (Table 1; Suppl. Table S2A and
B). Furthermore, Pkd1−/− have 529 unique DEG compared to Pkd1wt,
while 339 genes were exclusively altered in Pkd1wt cells in response to
ﬂuid shear stress (Fig. 1D–F; Table 1).
Fig. 1. Gene expression proﬁling in Pkd1−/− and Pkd1wt PTECs shows a strong diﬀerence between ﬂuid shear stress treated PTECs and static controls.
(A) Groups used for the in vitro RNA-sequencing study and the comparisons that were made between shear stress treated Pkd1−/− or Pkd1wt PTECs and static
controls. (B) Heat map representing the diﬀerentially expressed genes (p < 0.05; CPM > 2) identiﬁed in 4 shear stress treated Pkd1-/- (KO) samples (F= Flow) and
4 static controls (NF=No Flow). (C) Heat map of diﬀerentially expressed genes (p < 0.05; CPM > 2) identiﬁed in Pkd1−/− (KO) and Pkd1wt (WT) ﬂuid shear
stress treated samples and static controls. Unsupervised hierarchical clustering clearly distinguished ﬂuid shear from static controls and grouped Pkd1wt and Pkd1−/−
within these clusters. (B, C) Expression values were normalized using the Voom function in limma R package. Hierarchical clustering was applied and values were
scaled by row. (D–F) Venn diagrams of diﬀerentially expressed genes upon shear stress treatment or Pkd1 gene disruption in PTECs. The overlap between shear stress
treatment or Pkd1 gene disruption is shown for all (D), up- (E) or down-regulated (F) genes. (%) means the percentage of genes of all (D), up-regulated (E) or down-
regulated (F) genes.
Table 1
Diﬀerentially expressed genes by shear stress in and Pkd1−/− and Pkd1wt
PTECs.
Up Down Total
Pkd1−/− 943 806 1749
Pkd1wt 811 748 1559
Overlap 673 547 1220
Pkd1−/− only 270 259 529
Pkd1wt only 138 201 339
Number of diﬀerentially expressed genes (p < 0.05; CPM > 2) of shear stress
(ﬂow) versus static (no ﬂow) treated cultures in Pkd1−/− and Pkd1wt PTECs.
Low expressed genes were excluded with an enrichment ﬁlter of CPM (counts
per million) < 2. Pkd1−/− only or Pkd1wt only means genes diﬀerentially
expressed upon shear, uniquely in Pkd1−/− or Pkd1wt PTECs, respectively.
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3.2. Pkd1 induced transcriptional changes in PTECs
To further investigate diﬀerences between the Pkd1−/− and Pkd1wt
cells, we compared the gene expression proﬁles (Fig. 1A). In static
culture conditions there were 1644 genes diﬀerentially expressed be-
tween the Pkd1−/− and Pkd1wt cells, while there were 1775 DEG during
ﬂuid ﬂow (Table 2, Suppl. Table S2C and D). In total, 1280 genes were
diﬀerentially expressed due to the Pkd1 phenotype in both static and
ﬂow conditions, while smaller subsets of genes were uniquely diﬀer-
entially expressed in either of the two conditions (Fig. 1D–F). The lists
of diﬀerentially expressed genes in PTEC cells were further analyzed
using functional enrichment analysis.
3.3. Pathway analysis of altered gene expression upon ﬂuid shear in
Pkd1−/− and Pkd1wt PTECs
We used GeneTrail2 v1.5 as tool for functional enrichment analysis
[47] to identify biological pathways or processes associated with ﬂuid-
shear stress or the Pkd1 phenotype in PTECs (in vitro). The 4 lists of DEG
(Suppl. Table S2A–D) were split into up- and down-regulated genes in
order to get pathways that are generally up- or down-regulated. The up-
or down-regulated biological annotations by ﬂuid shear in Pkd1−/−
and Pkd1wt PTECs are presented in Supplementary Tables S3 and S4,
respectively. We subdivided the biological annotations in core signal
transduction, as well as cytokine/endocrine signaling, metabolism, cell-
cell/matrix interaction, other cellular processes and diseases. Ad-
ditionally, we used subgroup terms for the biological annotations si-
milar to the subgroups used in the KEGG database. Several pathways or
biological processes contain both up- or down-regulated genes, al-
though in most cases there were more up-regulated genes in the en-
riched biological annotations. Pathway analysis of unique shear regu-
lated genes in Pkd1−/− (270 up; 259 down) or Pkd1wt (138 up; 201
down) PTECs are presented in Supplementary Table S5.
3.3.1. Core signaling pathways altered upon shear stress
The most prominently altered signaling pathways by ﬂuid shear in
Pkd1−/− PTEC are the mitogen-activated protein kinase (MAPK) and
PI3K-AKT pathway (Table 3, Suppl. Table S3), which is similar to the
shear response in Pkd1wt PTEC (Suppl. Table S4). Both pathways have
clearly more up-regulated than down-regulated genes, while one of the
main inhibitors of the PI3K-AKT signaling, i.e. Pten, is down-regulated.
MAPK and PI3K-AKT signaling show various interactions with other
pathways that are altered by shear stress as well, both in Pkd1−/− and
Pkd1wt PTECs, including TGF-β, Wnt, p53 and JAK-STAT [19,20]. Of
those pathways, TGF-β, Wnt, and p53 had clearly more up-regulated
genes, suggesting that these pathways are up-regulated. In contrast,
only JAK-STAT signaling contains more genes that were down-regu-
lated, including receptors (Ifngr1, Il6st, Lifr) and signal transducers
(Stat1, Stat5a, Irf9). Furthermore, our results indicate that Hippo, Rap1,
Ras, TNF, FoxO, calcium, HIF-1, VEGF, mTOR and ErbB signaling are
altered as well by ﬂuid shear, both in Pkd1−/− and Pkd1wt PTEC
(Tables 3, S3 and S4). Furthermore, there are no pathways altered ex-
clusively in Pkd1−/− or Pkd1wt cells, but pathways are more or less
active (Suppl. Table S5).
Altered Hippo signaling is probably attributed to interaction of
YAP/TAZ with the TGF-β and Wnt signaling pathways, resulting in
increased expression of Smad2/3 targets (Serpine1, Ctgf, Smad7) and
TCF/LEF targets (Myc, Cd44 and Wisp1), while transcriptional reg-
ulators Taz (Wwtr1), Tead4, Tcf7l1 and Axin2 are increased upon shear
in Pkd1−/− PTECs only (Suppl. Table S5). Rap1 and Ras are core signal
transducers of MAPK and PI3K-AKT signaling and show up-regulation
of signaling related genes (Rap1b, Rapgef5, Rras), while several in-
hibitors of Rap1 and Ras (Rap1gap, Rasa1, Rasal2, Rasa4, Syngap1,
Sipa1l2) and cytokines (Angpt, Csf, Fgf, Igf, Pgf, Vegf) were altered as
well, contributing to the up-regulation of Rap1/Ras eﬀectors (Ets1, Ets2,
Rassf1, Rassf5, Rin1). In addition, activity of FoxO transcription factors
can be modulated by MAPK, PI3K-AKT, JAK-STAT and insulin sig-
naling, thereby modulating gene transcription upon interaction with
Smad3/4 transcription factors. This FoxO-Smad interaction is revealed
by shear induced up-regulation of genes involved in cell cycle (Ccng2,
Cdkn2b, Cdkn1a, Plk2, Plk3) and DNA repair (Gadd45a, Gadd45b,
Gadd45g), while other cell cycle genes were down-regulated (Cdkn2d,
Rbl2), as well as autophagy genes (Bnip3, Gabarapl1). Altered TNF, FGF,
PDGF, VEGF and ErbB signaling upon shear stress is attributed to al-
tered gene expression of ligands (Csf1, Csf3, Fgf1, Fgf9, Hbegf, Igf1,
Pdgfa, Pdgfb, Pdgfc, Vegfa, Vegfb) and receptors (Egfr, Fgfr1, Fgfr2,
Tnfrsf1b, Tnfrsf12a, Tnfrsf19, Tnfrsf21, Tnfrsf23, Relt), while down-
stream components of MAPK and PI3K-AKT signaling are modulated as
well.
3.3.2. Other biological processes altered upon shear stress
Expression of genes involved in various other cytokine and endo-
crine signaling pathways were also altered by shear in both Pkd1−/−
and Pkd1wt PTEC, including interleukin, insulin, B cell receptor,
thyroid, estrogen, T cell receptor and chemokine signaling pathways.
Altered expression include genes from aforementioned core signaling,
as well as additional genes, including chemokines with C-C or C-X-C
motifs (Ccl2, Cx3cl1, Cxcl10, Cxcr4, Ccl27a, Cxcl15). Regulation of cell-
cell and extracellular matrix (ECM) interactions were altered by ﬂuid
shear in Pkd1−/− and Pkd1wt PTEC, whereas much more genes involved
in these interactions are up-regulated, including several actins, actinin,
cadherins, β-catenin, cell adhesion molecules, collagens, ﬁbronectin,
integrins and laminins. The glycosaminoglycan biosynthesis pathway is
induced by shear, which is involved in glycocalyx remodeling.
Although several genes were diﬀerentially expressed in both Pkd1−/−
and Pkd1wt PTEC, a number of genes (Hs2st1, Hs3st3b1, Sdc1 and Sdc2)
were only induced by shear in Pkd1wt, suggesting that this pathway is
more controlled in Pkd1wt cells (Suppl. Table S5). Genes involved in
endocytosis were also increased by ﬂuid shear in PTECs, which was
reported in previous studies as well [48–50]. Genes involved in purine
metabolism were altered by shear stress as well, which showed an equal
number of up- and down-regulated genes. These include genes involved
in cAMP processing (Adcy1, Adcy7, Adcy9, Pde4d, Pde7a), adenine nu-
cleotide homeostasis (Ak1, Ak2, Ak4, Ak5), and RNA transcription
(Polr1b, Polr3d, Polr3e). Genes involved in energy, carbohydrate, amino
acid and cholesterol metabolism were mainly down-regulated by shear
stress in Pkd1−/− and Pkd1wt PTECs, while several other genes involved
in energy metabolism and lysosomal degradation were exclusively
down-regulated in Pkd1-/- cells (Suppl. Table S5). Other cellular pro-
cesses altered by shear stress include the protein-protein interactions,
Rho GTPase cycle and collagen metabolism. Only a small number of
genes involved in apoptosis and cell cycle were altered by shear, in-
dicating that these processes are not dramatically altered during shear
exposure.
Table 2
Diﬀerentially expressed genes in Pkd1−/− vs Pkd1wt PTECs.
Up Down Total
No ﬂow 828 816 1644
Flow 943 832 1775
Overlap 656 624 1280
No ﬂow only 172 192 364
Flow only 287 208 495
Number of diﬀerentially expressed genes (p < 0.05; CPM > 2) of Pkd1−/− vs
Pkd1wt PTECs during static (no ﬂow) or ﬂuid shear stress (ﬂow) conditions. Low
expressed genes were excluded with an enrichment ﬁlter of CPM (counts per
million) < 2. No ﬂow only or ﬂow only means genes uniquely diﬀerentially
expressed in Pkd1−/− vs Pkd1wt PTECs under static (no ﬂow) or shear exposure
(ﬂow), respectively.
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3.3.3. Cilia related gene expression upon shear stress
To investigate whether shear is aﬀecting structural components of
the cilium, we compared diﬀerential gene expression upon ﬂuid ﬂow
with the SysCilia Goldstandard database for cilia related genes (http://
www.syscilia.org/goldstandard.shtml). Only a minority of cilia genes
was diﬀerentially expressed by shear and these genes were not involved
in a speciﬁc cilia-assembly mechanism (Suppl. Table S6). Therefore, we
conclude that shear stress does not result in major structural alterations
in the experimental time-frame of 6 h.
From the pathway analysis we conclude that shear stress exposure
in Pkd1−/− and Pkd1wt PTEC modiﬁed expression of genes involved in
the same signaling pathways and biological processes, suggesting that
Pkd1 is not directly involved in shear dependent activation of these
pathways. These altered processes include several core signaling path-
ways, cytokine/endocrine pathways, cell-cell and ECM interactions,
endocytosis, and various metabolic pathways. However, there were
several genes involved in Hippo, Wnt and calcium signaling exclusively
altered by shear in Pkd1-/- PTECs, while some important genes in the
glycosaminoglycan biosynthesis were uniquely increased by shear in
Pkd1wt PTECs (Suppl. Table S5). Nevertheless, these pathways or mo-
lecular mechanisms are not uniquely altered in Pkd1-/- or Pkd1wt cells,
but our data show that the pathways are more or less active.
3.4. Diﬀerential activation of signaling in Pkd1−/− compared to Pkd1wt
PTECs
We compared the canonical signaling pathways that were altered by
shear stress in Pkd1−/− vs Pkd1wt PTECs. Scatter plots were constructed
comparing the log2 fold change (log2 FC) values of diﬀerentially ex-
pressed genes by ﬂuid shear in Pkd1−/− vs Pkd1wt PTEC cultures nor-
malized to their respective static controls (Suppl. Fig. S1). These plots
show a substantial number of genes that have a higher log2 FC for
Pkd1−/− cells for up-regulated (KEGG) pathways (MAPK, PI3K-AKT,
Hippo, Rap1, Wnt, TNF, Ras and TGF-β), while this phenomenon was
less evident for down-regulated pathways. These genes are more ele-
vated in Pkd1-/- PTECs upon shear stress exposure compared to Pkd1wt
controls (Fig. 2), which we previously showed for TGF-β target genes
[19]. Nevertheless, some of the pathways contain genes that are not
diﬀerentially expressed between Pkd1−/− cells and Pkd1wt controls.
Diﬀerential gene expression between Pkd1−/− vs Pkd1wt PTECs, pre-
sented in Suppl. Table S2C and D, was further assessed using functional
enrichment analysis (Suppl. Tables S7 and S8).
3.4.1. Core signaling pathways altered upon in vitro Pkd1 gene disruption
Evaluating the absolute expression levels in Pkd1−/− compared to
Pkd1wt PTECs, revealed higher expression of genes involved in PI3K-
AKT, Rap1, Hippo, MAPK, Ras, HIF-1, Wnt and TGF-β signaling path-
ways in shear-induced Pkd1−/− cells (Table 4, Suppl. Tables S7 and
S8). Furthermore, FoxO, TNF, p53, calcium, hedgehog and JAK-STAT
signaling were altered in Pkd1−/− PTECs as well. Most of the signaling
pathways with altered expression in Pkd1−/− PTECs contain more up-
regulated genes.
3.4.2. Other biological processes altered upon in vitro Pkd1 gene disruption
Other cytokine/endocrine signaling pathways are altered in Pkd1−/
− PTEC as well, including GnRH, interleukin, insulin, thyroid and cy-
tokine signaling. Biological processes that are increased in Pkd1−/−
PTEC compared to Pkd1wt PTEC include cholesterol biosynthesis,
prostaglandin synthesis, carbohydrate and purine metabolism, while
glycosaminoglycan metabolism is down-regulated. Several genes in-
volved in cell-cell, extracellular matrix and semaphorin interactions
were altered in Pkd1−/− cells, although there were both up- and down-
regulated genes involved in these interactions. Interestingly, genes in-
volved in endocytosis and circadian regulation were induced in Pkd1−/
− cells compared to Pkd1wt. Several cell cycle and apoptosis regulating
genes were altered as well.
From the in vitro functional enrichment analysis, we conclude that
several core signaling pathways and cellular processes were altered by
both shear stress and Pkd1 gene disruption, including PI3K-AKT, MAPK,
Ras, Rap1, Hippo, Wnt and TGF-β signaling, as well as endocytosis and
purine, cholesterol, carbohydrate and glycosaminoglycan metabolism.
In addition, shear induced expression of several genes was stronger in
Pkd1−/− PTECs.
3.5. Comparison of Pkd1 gene disruption in vitro and in vivo
Expression proﬁles of in vitro Pkd1−/− PTECs were compared with
the RNA-sequencing data of the in vivo iKsp-Pkd1del conditional knock-
out (cKO) mice (Suppl. Table S9). In the iKsp-Pkd1del (adult) mouse
model Pkd1 gene disruption is speciﬁcally induced in renal epithelial
cells, with the largest proportion in proximal tubular epithelial cells. In
the early phase upon in vivo Pkd1 disruption, there is still ﬂuid ﬂow, but
no Pkd1 expression in 40–50% of cells [36,38]. For this reason, the in
vitro Pkd1 phenotype during ﬂuid shear exposure will be compared to
the gene expression proﬁle of early phase adult iKsp-Pkd1del mice at 2, 3
or 6 weeks after gene disruption. At these pre-cystic time-points the
kidneys did not show any sign of cyst formation and had 2KW/BW
ratios comparable to Pkd1wt mice (Fig. 3), while this iKsp-Pkd1del model
reaches end stage renal disease (ESRD) at 20 weeks after Pkd1 gene
disruption (Suppl. Fig. S2). The number of diﬀerentially expressed
genes in iKsp-Pkd1del mice (2, 3 or 6 weeks) versus wild-type controls
was higher compared to ﬂow-stimulated Pkd1−/− versus Pkd1wt PTEC
cells (Fig. 4A, Suppl. Table S2D, S9A–C). There was an overlap of 131
genes up-regulated and 48 genes down-regulated upon Pkd1 disruption
in Pkd1−/− PTEC cells and all three iKsp-Pkd1del mice groups (Fig. 4B
and C, Suppl. Table S10). The comparison between in vitro and in vivo
Pkd1del models was further assessed using functional enrichment ana-
lysis.
3.5.1. Core signaling pathways altered upon Pkd1 gene disruption
Altered gene expression caused by Pkd1 disruption in both ﬂow-
stimulated Pkd1−/− PTEC cells and Pkd1del mice was attributed to
changes in several core signaling pathways, including PI3K-AKT, Rap1,
Hippo, MAPK, Ras, FoxO, HIF-1, p53, calcium, Wnt, Hedgehog, JAK-
STAT, TGF-β and TNF signaling (Fig. 5, Suppl. Figs. S3–S5, Suppl. Table
S11). Most of the pathways had more up-regulated than down-regu-
lated genes (Fig. 5), indicating that these signaling cascades are induced
in Pkd1−/− PTEC cells and Pkd1del mice compared to Pkd1wt controls. A
subset of genes in these pathways is identical but also paralogous genes
were changed upon Pkd1 disruption in cells and mice (Suppl. Fig. S3,
Suppl. Table S11). For example, Itgb6 in the PI3K/AKT pathway is up-
regulated in Pkd1−/− PTEC cells and Pkd1del mice, while several other
integrin’s were also up-regulated upon Pkd1 gene disruption in the
diﬀerent models. Altered expression of identical genes in cells and mice
is also observed for various signal transducers (Adcy1, Ccng1, Egfr, Il6st,
Itpkb), transcription factor (Creb3l2), inhibitors (Bcl2l1, Cdkn1a, Lats1,
Nfkbia, Pten, Sipa1l) and other genes (Atp2a2, Camk2d, Pard6b, Plau), as
well as several paralogous genes, like collagens (Col), laminins (Lam),
phospholipases (Pla), protein kinases (Mapk, Prk, Jak, Pik3, Rapgef),
phosphatases (Dusp, Ppp), growth factors (Bmp, Ctgf, Pdgf, Tgfb), re-
ceptors (Fgfr, Pdgfr) and transcriptions factors (Creb, Foxo, Smad, Tead).
These genes are active in several of the aforementioned pathways,
suggesting that these genes might contribute to the Pkd1 phenotype,
since they are altered in both in vitro and in vivo Pkd1del models. In
contrast, altered expression of genes involved in Wnt signaling did not
show a clear overlap between the in vitro and in vivo RNA sequencing
data (Suppl. Table S11), but the overall eﬀect in the two models in-
dicates decreased non-canonical Wnt signaling. In Pkd1−/− PTEC cells,
there is altered expression of several canonical Wnt ligands (Wnt pro-
teins), receptors (Fz’s), transcription factors (up: Lef1, Tcf7l2; down:
Tcf7l1, Tcf7) and modulators (up: Sfrp2; down: Frat2, Porcn, Sfrp1),
while non-canonical Wnt proteins (Vangl1, 2, Prickle1) and Ca2+
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dependent NFAT (Nfatc1,4) transcription factors were decreased, which
might suggest decreased non-canonical Wnt. In Pkd1del mice there is
decreased expression of several β-catenin inhibitors (Chd8, Rb, Skp1a,
Sox17), while expression of β-catenin (Ctnnb1) itself is increased, as
well as receptors (Fz’s and Lrp5,6) and target genes (Axin1, Ccnd1,
Ccnd2, Ppard), suggesting increased canonical Wnt signaling. Down-
regulation of Dvl1 and Wnt proteins that activate non-canonical Wnt
(Wnt5b, Wnt7b, Wnt11) may also suggest reduced non-canonical Wnt-
signaling.
3.5.2. Other biological processes altered upon Pkd1 gene disruption
Other altered signaling pathways with mainly up-regulated genes in
Pkd1−/− cells and mice include cytokine/endocrine signaling (GPCR,
GnRH, interleukin, insulin, thyroid and estrogen signaling) as depicted
in Supplementary Figure S4-5 and Table S11. Genes involved in protein
interactions, ECM interactions, endocytosis, focal adhesion, cell adhe-
sion, actin cytoskeleton, endoplasmic reticulum protein processing,
adipogenesis, purine metabolism and circadian regulation were altered
as well in both Pkd1−/− cells and Pkd1del mice compared to Pkd1wt
controls. Cholesterol biosynthesis was up-regulated in vitro, but not in
vivo, while lysosome related gene expression was only up-regulated in
vivo. Genes involved in mRNA processing, protein translation, ribo-
somal proteins and electron transport were only down-regulated in
iKsp-Pkd1del mice (Suppl. Figure S5). This was attributed to down-
regulation of various ATP synthases and transporters, NADH ubiqui-
none oxidoreductases, cytochrome C oxidases and reductases, eu-
karyotic translation initiation factor, RNA polymerases, general tran-
scription factors, splicing factors and ribosomal proteins.
From the comparison between the in vitro and in vivo RNA sequen-
cing data and pathway analysis we conclude that various identical and
paralogous genes were altered upon Pkd1 gene disruption in both
model systems. These genes are already altered in the pre-cystic phase
and are involved in several core signaling pathways, which suggest that
these processes may contribute to in vivo cyst formation.
4. Discussion
In this study we present an overview of transcriptome alterations
upon ﬂuid shear stress exposure and Pkd1 gene disruption in proximal
tubular epithelial cells. We compared gene expression proﬁles of shear
stress treated Pkd1−/− PTECs with Pkd1wt controls and showed that
1219 genes were altered by ﬂuid shear in both cell lines. Functional
enrichment analysis revealed that shear regulated genes in Pkd1−/−
and Pkd1wt PTECs are involved in the same signaling pathways. Shear
stress activated pathways include MAPK, PI3K-AKT, TGF-β, Wnt, p53,
Hippo, FoxO, calcium and mTOR signaling, while only JAK-STAT sig-
naling is down-regulated upon shear. Several of these pathways have
been published previously [9,15–21,32]. Increased intracellular Ca2+ is
one of the ﬁrst responses of epithelial cells to the onset of shear, thereby
modulating several signaling cascades, but it is currently under debate
if the Ca2+ inﬂux is cilium dependent [9,21,23–25,51]. In addition, the
cilium is only involved in part of the shear stress response of PTECs,
suggesting that other mechano-sensing complexes are involved as well
[19,20].
Previously, we showed that inhibitors of TGF-β and MAPK/ERK
signaling modulate a wide range of mechanosensitive genes, identifying
these pathways as master regulators of shear-induced gene expression
[19,20]. This is attributed to the many interactions of TGF-β and MAPK
signaling with other pathways. One of these pathways is Hippo sig-
naling, which controls organ size in animals and is modulated upon
ﬂuid shear. Interaction of the core components YAP and TAZ (also
called Wwtr1) with TGF-β and Wnt signaling pathways has been de-
scribed previously, thereby regulating Smad2/3 and TCF/LEF target
gene expression, respectively [52–55]. In addition, activity of FoxO
transcription factors can be modulated by MAPK, PI3K-AKT, JAK-STAT
and insulin signaling, thereby modulating gene transcription upon
Fig. 2. Comparison of shear stress response in Pkd1−/− and Pkd1wt PTECs.
Comparison of log2 fold changes (log2 FC) in Pkd1−/− PTECs and Pkd1wt controls for diﬀerentially up-regulated (A) or down-regulated (B) genes upon shear stress
treatment, normalized to their respective static controls. Several shear up-regulated genes show stronger shear induction in Pkd1−/− PTECs compared to Pkd1wt
controls. For shear down-regulated genes there were less genes diﬀerentially expressed between Pkd1−/− and Pkd1wt PTECs. Only the genes are shown that were
annotated to canonical signaling pathways (KEGG) using functional enrichment, as presented in Supplementary Tables S3–S4 and Fig. S1. All genes presented have a
signiﬁcantly diﬀerent shear stress response between Pkd1−/− vs Pkd1wt PTECs (p < 0.05 by a two-sample t-test with Welch’s correction).
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interaction with Smad3/4 transcription factors [56].
Other shear regulated pathways include TNF, FGF, PDGF, VEGF and
ErbB signaling, for which functional enrichment is largely attributed to
altered gene expression of ligands, receptors and downstream compo-
nents of MAPK and PI3K-AKT signaling. Important signal transducers of
MAPK and PI3K-AKT signaling are Ras and Rap1, which shows again
the interaction between cellular signaling pathways. Shear induced
activation of several other cytokine or endocrine signaling pathways
and shear altered expression of genes involved in cell-cell contacts,
ECM, glycocalyx remodeling and endocytosis has been discussed in
Kunnen et al. [20]. Remarkably, several genes involved in energy me-
tabolism and autophagy (the process of lysosomal degradation) were
exclusively down-regulated by shear stress in Pkd1−/− PTECs. These
processes are also implicated in ADPKD, but how it aﬀects cyst pro-
gression is currently unclear [57,58]. These ﬁndings suggest a complex
interaction of processes and pathways to regulate the shear stress re-
sponse in PTECs and to maintain cellular physiology.
Shear stress induced expression of a number of genes involved in
MAPK, PI3K-AKT, Hippo, Rap1, Wnt, TNF, Ras and TGF-β was slightly
more activated in Pkd1−/− PTECs compared to Pkd1wt controls (Figs. 2
and S1), which we previously showed for TGF-β/ALK5 target genes
[19]. Similarly, genes with diﬀerential expression in Pkd1−/− PTECs
compared to Pkd1wt cells, were indeed involved in PI3K-AKT, Rap1,
Hippo, MAPK, Ras, Wnt and TGF-β signaling, which indicates that shear
induced gene expression is further elevated due to Pkd1 gene disrup-
tion. In addition, functional enrichment analysis of shear regulated
genes that were exclusively induced in Pkd1−/− PTECs conﬁrms that a
subset of these genes is involved in Hippo, Wnt, MAPK and calcium
signaling (Suppl. Table S5). These include several transcriptional reg-
ulators of the Hippo and Wnt signaling pathways. Overall, these data
suggest that Pkd1 has the function to restrain shear regulated signaling
instead of being a mechano-sensing activator. Accordingly, Ma et al.
previously proposed a role for Pkd1 in restraining an unknown cilia-
dependent signaling pathway involved in cyst formation [59]. Further
research is required to investigate if and how Pkd1 is inhibiting shear
induced signaling. In addition, pathological shear stress can also elevate
gene expression of aforementioned pathways compared to physiolo-
gical levels of shear [20]. Moreover, strong variations in ﬂuid shear
stress are common in kidney diseases, including ADPKD, due to tubular
dilation obstruction and hyperﬁltration, which occur in functional ne-
phrons, to compensate for lost glomeruli and tubules [34]. Increased or
pathological shear stress after unilateral nephrectomy [35,36], can
accelerate cyst formation in a Pkd1−/−mouse model [38]. This leads to
the hypothesis that pathological shear stress and Pkd1 gene disruption
can both cause imbalanced cellular signaling, which may contribute to
renal cyst formation and ﬁbrosis.
To study shear stress dependent signaling in ADPKD, we compared
changes in gene expression in Pkd1−/− PTECs during shear with in vivo
transcriptome analysis of pre-cystic kidneys in mice. In the iKsp-Pkd1del
mouse model Pkd1 gene disruption is speciﬁcally induced in around
40–50% of the renal epithelial cells, with the largest proportion in
proximal tubular epithelial cells [36,38]. In the early phase upon in vivo
Pkd1 disruption, there is still ﬂuid ﬂow without signs of cyst formation.
In contrast, in the late/end phase of PKD, there are many cysts and
Fig. 3. Kidney morphology and kidney weight (KW/BW) of Pkd1wt and pre-
cystic iKsp-Pkd1del mice.
(A) Representative images of periodic-acid Schiﬀ (PAS) staining on formalin
ﬁxed, paraﬃn embedded kidney sections of Pkd1wt (top left) and iKsp-Pkd1del
mice at 2 (top right), 3 (bottom left) or 6 (bottom right) weeks after gene
disruption. No visual diﬀerence in kidney morphology between Pkd1wt and pre-
cystic iKsp-Pkd1del mice; scale bar= 100 μm. (B) Similar kidney weight to body
weight ratio’s (2KW/BW%) in Pkd1wt and iKsp-Pkd1del mice at 2, 3 or 6 weeks
after gene disruption.
Fig. 4. Comparison of DEG upon Pkd1 gene disruption in Pkd1−/− cells and iKsp-Pkd1del mice.
(A) Number of diﬀerentially up- or down-regulated genes in Pkd1−/− PTECs or iKsp-Pkd1del (cKO) mice at 2, 3 or 6 weeks (WK) after gene disruption. (B, C) Venn
diagram of up-regulated (B) and down-regulated (C) genes showing the number of genes in overlap between Pkd1−/− PTEC cells and iKsp-Pkd1del mice. (%) means
the percentage of genes of all up-regulated or down-regulated genes.
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ﬁbrotic tissue, causing disturbance or loss of ﬂuid ﬂow in numerous
nephrons. At this stage, the remaining nephrons experience increased
ﬂuid shear to compensate for the cystic or ﬁbrotic tissue. Therefore,
altered signaling of biological pathways or processes in late phase PKD
can be caused by several factors, like loss of ﬂuid shear, increased shear,
increased pressure, changes in tissue composition, ﬁbrosis or in-
ﬂammation [60]. For this reason, the in vitro Pkd1 phenotype during
ﬂuid shear exposure in PTECs was compared with the gene expression
proﬁles of pre-cystic adult iKsp-Pkd1del mice at 2, 3 or 6 weeks after
Pkd1 gene disruption [46].
In the comparison between the in vitro and in vivo transcriptome
analysis we identiﬁed 131 genes up-regulated and 48 genes down-
regulated in Pkd1−/− PTECs and iKsp-Pkd1del mice at all three time
points (Suppl. Table S10). Therefore, we can conclude that these genes
are already altered in the earliest phase upon Pkd1 gene disruption.
Looking at the pathways and molecular processes, we noticed extensive
overlap between cells and mice, although this can largely be attributed
to the expression of paralogous genes, rather than to the identical
genes. Examples include collagens, integrins, kinases, phosphatases,
growth factors, receptors, signal transducers, inhibitors and transcrip-
tion factors. These genes are involved in several core signaling path-
ways (Suppl. Table S11) of which several are known to be implicated in
ADPKD (i.e. PI3K-AKT, MAPK, Hippo, JAK-STAT and TGF-β signaling)
[39,45,55,61–74], suggesting that these pathways are already modiﬁed
at pre-cystic stage.
Interpretation of the Wnt signaling is complex since canonical
(Wnt/β-catenin) or non-canonical (β-catenin-independent) Wnt sig-
naling share components, but also may have reciprocal eﬀects. In ad-
dition, non-canonical Wnt signaling can be subdivided into the Wnt/
planar cell polarity (PCP) and Wnt/Ca2+ pathways. Genes involved in
Wnt signaling do not show much overlap between in vitro and in vivo
transcriptome data, however, the overall picture suggests decreased
non-canonical Wnt signaling in Pkd1−/− cells and mice. Increased ca-
nonical Wnt might be involved in cyst formation, although aberrant
PCP signaling at early stage has been suggested as well [67,75]. Recent
data suggest that the polycystin-complex itself mediates Wnt-induced
Ca2+ signaling, although independent of Fz-receptors [76,77].
Interestingly, several genes involved in endocytosis showed altered
expression in Pkd1del mice and PTEC cells, while this process was also
increased by in vitro ﬂuid shear exposure [48–50]. The involvement of
endocytosis in several growth factor signaling cascades like TGF-β and
MAPK [28,78], makes this ﬁnding more interesting, suggesting that
altered endocytosis, upon shear stress or Pkd1 gene disruption, might
contribute to imbalanced signaling.
Besides the clear overlap in altered cellular signaling between
Pkd1−/− cells and Pkd1del mice, there were some diﬀerences. Genes
involved in oxidative phosphorylation, mRNA processing, protein
translation and ribosomal proteins were explicitly down-regulated in
iKsp-Pkd1del mice, while lysosome related gene expression was up-
regulated. This might be caused by the diﬀerent cell types that are
present in the kidney, as well as variations in shear stress, and will
depend on the overall biological context.
It has been hypothesized that critical Polycystin-1 levels are needed
to restrain cellular and cilia related signaling [59,79]. Increased acti-
vation of selected genes in renal epithelial cells upon Pkd1 gene dis-
ruption, as shown in this paper, may disturb the balance in signaling
and might contribute to cyst formation. Of course, the signaling cas-
cades that trigger cyst formation will depend on several factors, in
addition to local and functional PKD protein levels, like renal injury,
shear stress, inﬂammation, the metabolic status and more general, the
biological context [60]. For example, a number of studies indicate that
renal injury can accelerate cyst progression and ﬁbrosis [67,80,81].
Numerous pre-clinical studies eﬀectively inhibited implicated signaling
pathways and reduced cyst formation and ﬁbrosis. However, various
clinical studies were unsuccessful to delay cyst growth in patients,
while only Tolvaptan, a vasopressin receptor antagonist, has been ap-
proved as drug for ADPKD patients in a number of countries [82–86].
Therefore, eﬀective therapies should target multiple signaling path-
ways, to re-establishing the balance in cellular signaling in renal epi-
thelial cells and to maintain cellular homeostasis within physiological
boundaries [60,87,88].
5. Conclusions
In conclusion, shear stress alters the same signaling pathways in
Pkd1−/− PTECs and in Pkd1wt controls in vitro. However, the expression
of a substantial number of genes was slightly more elevated by shear in
Pkd1−/− compared to Pkd1wt cells, which are involved in Hippo, Wnt,
MAPK, TGF-β and calcium signaling. Based on these results we hy-
pothesize that Pkd1 restrains shear stress induced signaling, rather than
Fig. 5. Core signaling pathways altered upon Pkd1 gene disruption in Pkd1−/− cells and iKsp-Pkd1del mice.
Number of diﬀerentially expressed genes per condition, which were annotated to up-regulated (A) or down-regulated (B) core signaling pathways (KEGG) for Pkd1−/
− PTECs or iKsp-Pkd1del (cKO) mice at 2, 3 or 6 weeks (WK) after gene disruption. Pathways are ordered by lowest false discovery rate (FDR) of up-regulated
pathways in Pkd1−/− PTECs. #=Not signiﬁcantly enriched pathways in Pkd1−/− PTECs from functional enrichment analysis (FDR> =0.01).
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being directly involved in shear dependent activation of these path-
ways.
A comparison of shear-induced changes in Pkd1−/− PTECs with in
vivo transcriptome data of kidneys at three early pre-cystic time-points,
revealed overlap in pathways and molecular processes, involving
identical genes (approx. 180) as well as paralogous genes. These
pathways include PI3K-AKT, MAPK, JAK-STAT, Hippo, p53, calcium,
Wnt and TGF-β signaling, which are known to be implicated in the
renal cyst formation as well. So, our results suggest that these processes
are already altered at pre-cystic stage and may contribute to in vivo cyst
formation caused by imbalanced signaling upon Pkd1 gene disruption.
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